391267-29-1
391267-29-1
Chemical Structure
IMP 243
- CAS No.: 391267-29-1
- Formula:C57H86N20O14S2
- Molecular Weight:1339.55
InChIKey: CWGLLPDNNMQXPN-PDKNMLPSSA-N
SMILES: O=C(CCC(NCC(NCCCC[C@@H](C(N[C@@H](C(N[C@H](C(N[C@H](C(N)=O)CCCCNC([C@H](CS)NC(/C=N\NC(N)=S)=O)=O)=O)CCCCNC(CNC(CCC(NCCC1=CNC=N1)=O)=O)=O)=O)CC2=CC=C(O)C=C2)=O)NC(C)=O)=O)=O)NCCC3=CNC=N3
Biological Activity: IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
IMP 243 | IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
